Last edition
News about "polycythemia vera "
US FDA Approves First Drug for Polycythemia Vera
The US Food and Drug Administration (FDA) has approved the first-in-class drug for polycythemia vera, targeting the underlying biology driving excessive Red Blood Cell (RBC) production.
Polycythemia Vera | 31/08/2026 | By News Bureau
Vanda Pharmaceuticals Receives Orphan Drug Designation Granted for VGT-1849A
VGT-1849A is a novel ASO treatment candidate for PV and other JAK2-driven hematologic malignancies.
Polycythemia Vera | 21/12/2024 | By Aishwarya | 1053
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy